The Use of Carbon Quantum Dot as Alternative of Stannous Chloride Application in Radiopharmaceutical Kits
Even today, technetium-99m is a radionuclide choice for diagnostic in nuclear medicine. The unique chemical and physical properties of technetium-99m make it suitable as an available radionuclide in many centers. In this study, we examined the potential of CQD as a reducing agent in the MDP kit. Cit...
Gespeichert in:
Veröffentlicht in: | Contrast media and molecular imaging 2020-11, Vol.2020 (2020), p.1-11 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 11 |
---|---|
container_issue | 2020 |
container_start_page | 1 |
container_title | Contrast media and molecular imaging |
container_volume | 2020 |
creator | Ardestani, Mehdi Shafiee Alikhani, Zahra Mirzaei, Mehdi Etemadzade, Maziyar Seyedhamzeh, Mohammad Yadegari, Sina Najdian, Atena Ghoreishi, Seyedeh Masoumeh Hadadian, Shahin |
description | Even today, technetium-99m is a radionuclide choice for diagnostic in nuclear medicine. The unique chemical and physical properties of technetium-99m make it suitable as an available radionuclide in many centers. In this study, we examined the potential of CQD as a reducing agent in the MDP kit. Citric acid-derived CQD was synthesized and confirmed by FT-IR, TEM, UV-Vis, XPS, and surface analysis. No cytotoxicity was observed by the MTT assay. They were reducing properties of the CQD confirmed by fluorescence microscopy. The MDP kit is prepared by evaluating different parameters that affect the radiolabeling yield, including ligand, time, and CQD. The optimum amount of each parameter is obtained by Box–Behnken software. Finally, fluorescent spectroscopy, SPECT imaging, and biodistribution study showed that CQD reduces technetium-99m. Accumulation of radiotracer in the femur showed that CQD could be used in a radiopharmaceutical kit. |
doi_str_mv | 10.1155/2020/4742158 |
format | Article |
fullrecord | <record><control><sourceid>emarefa_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1155_2020_4742158</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1139251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-879d58dba52630c1f046926e8312d2f8d4211a12e84e66f9950152f74a28e1e33</originalsourceid><addsrcrecordid>eNqF0M9LwzAUB_AgCs7pzbPkrnX52abHUX_iQNTtXN7ahEa6tCSp4n9v54YePeWR93kP3hehc0quKZVyxggjM5EJRqU6QJPxSyaC0-zwtyb5MToJ4Z0QIXjOJ8guG41XQePO4AL8unP4ZQAXhw2-6SKGgOdt1N5BtB8_6C2Cc90QcNG0nbe1xvO-b201gnHWOvwKte36BvwGKj3EsdPiJxvDKToy0AZ9tn-naHV3uyweksXz_WMxXyQV5ywmKstrqeo1SJZyUlFDRJqzVCtOWc2MqsfrKFCmldBpavJcEiqZyQQwpanmfIqudnsr34XgtSl7bzfgv0pKym1M5Tamch_TyC93vLGuhk_7n77YaT0abeBPU54zSfk3syZwxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Use of Carbon Quantum Dot as Alternative of Stannous Chloride Application in Radiopharmaceutical Kits</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ardestani, Mehdi Shafiee ; Alikhani, Zahra ; Mirzaei, Mehdi ; Etemadzade, Maziyar ; Seyedhamzeh, Mohammad ; Yadegari, Sina ; Najdian, Atena ; Ghoreishi, Seyedeh Masoumeh ; Hadadian, Shahin</creator><contributor>Riou, Laurent M.</contributor><creatorcontrib>Ardestani, Mehdi Shafiee ; Alikhani, Zahra ; Mirzaei, Mehdi ; Etemadzade, Maziyar ; Seyedhamzeh, Mohammad ; Yadegari, Sina ; Najdian, Atena ; Ghoreishi, Seyedeh Masoumeh ; Hadadian, Shahin ; Riou, Laurent M.</creatorcontrib><description>Even today, technetium-99m is a radionuclide choice for diagnostic in nuclear medicine. The unique chemical and physical properties of technetium-99m make it suitable as an available radionuclide in many centers. In this study, we examined the potential of CQD as a reducing agent in the MDP kit. Citric acid-derived CQD was synthesized and confirmed by FT-IR, TEM, UV-Vis, XPS, and surface analysis. No cytotoxicity was observed by the MTT assay. They were reducing properties of the CQD confirmed by fluorescence microscopy. The MDP kit is prepared by evaluating different parameters that affect the radiolabeling yield, including ligand, time, and CQD. The optimum amount of each parameter is obtained by Box–Behnken software. Finally, fluorescent spectroscopy, SPECT imaging, and biodistribution study showed that CQD reduces technetium-99m. Accumulation of radiotracer in the femur showed that CQD could be used in a radiopharmaceutical kit.</description><identifier>ISSN: 1555-4309</identifier><identifier>EISSN: 1555-4317</identifier><identifier>DOI: 10.1155/2020/4742158</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><ispartof>Contrast media and molecular imaging, 2020-11, Vol.2020 (2020), p.1-11</ispartof><rights>Copyright © 2020 Seyedeh Masoumeh Ghoreishi et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-879d58dba52630c1f046926e8312d2f8d4211a12e84e66f9950152f74a28e1e33</citedby><cites>FETCH-LOGICAL-c332t-879d58dba52630c1f046926e8312d2f8d4211a12e84e66f9950152f74a28e1e33</cites><orcidid>0000-0001-9422-8441 ; 0000-0002-7091-1366 ; 0000-0002-0097-9779 ; 0000-0003-1632-4387 ; 0000-0003-2952-7431 ; 0000-0003-0300-4632 ; 0000-0002-3707-7082 ; 0000-0002-8658-5331 ; 0000-0001-5768-3269</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><contributor>Riou, Laurent M.</contributor><creatorcontrib>Ardestani, Mehdi Shafiee</creatorcontrib><creatorcontrib>Alikhani, Zahra</creatorcontrib><creatorcontrib>Mirzaei, Mehdi</creatorcontrib><creatorcontrib>Etemadzade, Maziyar</creatorcontrib><creatorcontrib>Seyedhamzeh, Mohammad</creatorcontrib><creatorcontrib>Yadegari, Sina</creatorcontrib><creatorcontrib>Najdian, Atena</creatorcontrib><creatorcontrib>Ghoreishi, Seyedeh Masoumeh</creatorcontrib><creatorcontrib>Hadadian, Shahin</creatorcontrib><title>The Use of Carbon Quantum Dot as Alternative of Stannous Chloride Application in Radiopharmaceutical Kits</title><title>Contrast media and molecular imaging</title><description>Even today, technetium-99m is a radionuclide choice for diagnostic in nuclear medicine. The unique chemical and physical properties of technetium-99m make it suitable as an available radionuclide in many centers. In this study, we examined the potential of CQD as a reducing agent in the MDP kit. Citric acid-derived CQD was synthesized and confirmed by FT-IR, TEM, UV-Vis, XPS, and surface analysis. No cytotoxicity was observed by the MTT assay. They were reducing properties of the CQD confirmed by fluorescence microscopy. The MDP kit is prepared by evaluating different parameters that affect the radiolabeling yield, including ligand, time, and CQD. The optimum amount of each parameter is obtained by Box–Behnken software. Finally, fluorescent spectroscopy, SPECT imaging, and biodistribution study showed that CQD reduces technetium-99m. Accumulation of radiotracer in the femur showed that CQD could be used in a radiopharmaceutical kit.</description><issn>1555-4309</issn><issn>1555-4317</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><recordid>eNqF0M9LwzAUB_AgCs7pzbPkrnX52abHUX_iQNTtXN7ahEa6tCSp4n9v54YePeWR93kP3hehc0quKZVyxggjM5EJRqU6QJPxSyaC0-zwtyb5MToJ4Z0QIXjOJ8guG41XQePO4AL8unP4ZQAXhw2-6SKGgOdt1N5BtB8_6C2Cc90QcNG0nbe1xvO-b201gnHWOvwKte36BvwGKj3EsdPiJxvDKToy0AZ9tn-naHV3uyweksXz_WMxXyQV5ywmKstrqeo1SJZyUlFDRJqzVCtOWc2MqsfrKFCmldBpavJcEiqZyQQwpanmfIqudnsr34XgtSl7bzfgv0pKym1M5Tamch_TyC93vLGuhk_7n77YaT0abeBPU54zSfk3syZwxg</recordid><startdate>20201106</startdate><enddate>20201106</enddate><creator>Ardestani, Mehdi Shafiee</creator><creator>Alikhani, Zahra</creator><creator>Mirzaei, Mehdi</creator><creator>Etemadzade, Maziyar</creator><creator>Seyedhamzeh, Mohammad</creator><creator>Yadegari, Sina</creator><creator>Najdian, Atena</creator><creator>Ghoreishi, Seyedeh Masoumeh</creator><creator>Hadadian, Shahin</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-9422-8441</orcidid><orcidid>https://orcid.org/0000-0002-7091-1366</orcidid><orcidid>https://orcid.org/0000-0002-0097-9779</orcidid><orcidid>https://orcid.org/0000-0003-1632-4387</orcidid><orcidid>https://orcid.org/0000-0003-2952-7431</orcidid><orcidid>https://orcid.org/0000-0003-0300-4632</orcidid><orcidid>https://orcid.org/0000-0002-3707-7082</orcidid><orcidid>https://orcid.org/0000-0002-8658-5331</orcidid><orcidid>https://orcid.org/0000-0001-5768-3269</orcidid></search><sort><creationdate>20201106</creationdate><title>The Use of Carbon Quantum Dot as Alternative of Stannous Chloride Application in Radiopharmaceutical Kits</title><author>Ardestani, Mehdi Shafiee ; Alikhani, Zahra ; Mirzaei, Mehdi ; Etemadzade, Maziyar ; Seyedhamzeh, Mohammad ; Yadegari, Sina ; Najdian, Atena ; Ghoreishi, Seyedeh Masoumeh ; Hadadian, Shahin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-879d58dba52630c1f046926e8312d2f8d4211a12e84e66f9950152f74a28e1e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ardestani, Mehdi Shafiee</creatorcontrib><creatorcontrib>Alikhani, Zahra</creatorcontrib><creatorcontrib>Mirzaei, Mehdi</creatorcontrib><creatorcontrib>Etemadzade, Maziyar</creatorcontrib><creatorcontrib>Seyedhamzeh, Mohammad</creatorcontrib><creatorcontrib>Yadegari, Sina</creatorcontrib><creatorcontrib>Najdian, Atena</creatorcontrib><creatorcontrib>Ghoreishi, Seyedeh Masoumeh</creatorcontrib><creatorcontrib>Hadadian, Shahin</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>CrossRef</collection><jtitle>Contrast media and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ardestani, Mehdi Shafiee</au><au>Alikhani, Zahra</au><au>Mirzaei, Mehdi</au><au>Etemadzade, Maziyar</au><au>Seyedhamzeh, Mohammad</au><au>Yadegari, Sina</au><au>Najdian, Atena</au><au>Ghoreishi, Seyedeh Masoumeh</au><au>Hadadian, Shahin</au><au>Riou, Laurent M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Use of Carbon Quantum Dot as Alternative of Stannous Chloride Application in Radiopharmaceutical Kits</atitle><jtitle>Contrast media and molecular imaging</jtitle><date>2020-11-06</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>1555-4309</issn><eissn>1555-4317</eissn><abstract>Even today, technetium-99m is a radionuclide choice for diagnostic in nuclear medicine. The unique chemical and physical properties of technetium-99m make it suitable as an available radionuclide in many centers. In this study, we examined the potential of CQD as a reducing agent in the MDP kit. Citric acid-derived CQD was synthesized and confirmed by FT-IR, TEM, UV-Vis, XPS, and surface analysis. No cytotoxicity was observed by the MTT assay. They were reducing properties of the CQD confirmed by fluorescence microscopy. The MDP kit is prepared by evaluating different parameters that affect the radiolabeling yield, including ligand, time, and CQD. The optimum amount of each parameter is obtained by Box–Behnken software. Finally, fluorescent spectroscopy, SPECT imaging, and biodistribution study showed that CQD reduces technetium-99m. Accumulation of radiotracer in the femur showed that CQD could be used in a radiopharmaceutical kit.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><doi>10.1155/2020/4742158</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-9422-8441</orcidid><orcidid>https://orcid.org/0000-0002-7091-1366</orcidid><orcidid>https://orcid.org/0000-0002-0097-9779</orcidid><orcidid>https://orcid.org/0000-0003-1632-4387</orcidid><orcidid>https://orcid.org/0000-0003-2952-7431</orcidid><orcidid>https://orcid.org/0000-0003-0300-4632</orcidid><orcidid>https://orcid.org/0000-0002-3707-7082</orcidid><orcidid>https://orcid.org/0000-0002-8658-5331</orcidid><orcidid>https://orcid.org/0000-0001-5768-3269</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1555-4309 |
ispartof | Contrast media and molecular imaging, 2020-11, Vol.2020 (2020), p.1-11 |
issn | 1555-4309 1555-4317 |
language | eng |
recordid | cdi_crossref_primary_10_1155_2020_4742158 |
source | PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
title | The Use of Carbon Quantum Dot as Alternative of Stannous Chloride Application in Radiopharmaceutical Kits |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A37%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-emarefa_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Use%20of%20Carbon%20Quantum%20Dot%20as%20Alternative%20of%20Stannous%20Chloride%20Application%20in%20Radiopharmaceutical%20Kits&rft.jtitle=Contrast%20media%20and%20molecular%20imaging&rft.au=Ardestani,%20Mehdi%20Shafiee&rft.date=2020-11-06&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=1555-4309&rft.eissn=1555-4317&rft_id=info:doi/10.1155/2020/4742158&rft_dat=%3Cemarefa_cross%3E1139251%3C/emarefa_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |